| Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy LS Sasportas, R Kasmieh, H Wakimoto, S Hingtgen, JAJM van de Water, ... Proceedings of the national academy of sciences 106 (12), 4822-4827, 2009 | 574 | 2009 |
| MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell–delivered S-TRAIL in human gliomas MF Corsten, R Miranda, R Kasmieh, AM Krichevsky, R Weissleder, ... Cancer research 67 (19), 8994-9000, 2007 | 542 | 2007 |
| Mesenchymal stem cell immunomodulation: mechanisms and therapeutic potential N Song, M Scholtemeijer, K Shah Trends in pharmacological sciences 41 (9), 653-664, 2020 | 448 | 2020 |
| Shattering barriers toward clinically meaningful MSC therapies O Levy, R Kuai, EMJ Siren, D Bhere, Y Milton, N Nissar, M De Biasio, ... Science advances 6 (30), eaba6884, 2020 | 441 | 2020 |
| Human glioblastoma–derived cancer stem cells: Establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors H Wakimoto, S Kesari, CJ Farrell, WT Curry Jr, C Zaupa, M Aghi, T Kuroda, ... Cancer research 69 (8), 3472-3481, 2009 | 407 | 2009 |
| Mesenchymal stem cells engineered for cancer therapy K Shah Advanced drug delivery reviews 64 (8), 739-748, 2012 | 378 | 2012 |
| TRAIL on trial: preclinical advances in cancer therapy DW Stuckey, K Shah Trends in molecular medicine 19 (11), 685-694, 2013 | 326 | 2013 |
| In vivo tracking of neural progenitor cell migration to glioblastomas Y Tang, K Shah, SM Messerli, E Snyder, X Breakefield, R Weissleder Human gene therapy 14 (13), 1247-1254, 2003 | 275 | 2003 |
| Brain tumor cells in circulation are enriched for mesenchymal gene expression JP Sullivan, BV Nahed, MW Madden, SM Oliveira, S Springer, D Bhere, ... Cancer discovery 4 (11), 1299-1309, 2014 | 249 | 2014 |
| Molecular imaging of gene therapy for cancer K Shah, A Jacobs, XO Breakefield, R Weissleder Gene therapy 11 (15), 1175-1187, 2004 | 246 | 2004 |
| Molecular optical imaging: applications leading to the development of present day therapeutics K Shah, R Weissleder NeuroRx 2, 215-225, 2005 | 237 | 2005 |
| Stem cell-based therapies for cancer treatment: separating hope from hype DW Stuckey, K Shah Nature Reviews Cancer 14 (10), 683-691, 2014 | 236 | 2014 |
| The Arabidopsis kinase-associated protein phosphatase controls internalization of the somatic embryogenesis receptor kinase 1 K Shah, E Russinova, TWJ Gadella, J Willemse, SC De Vries Genes & development 16 (13), 1707-1720, 2002 | 236 | 2002 |
| Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas TM Kauer, JL Figueiredo, S Hingtgen, K Shah Nature neuroscience 15 (2), 197-204, 2012 | 234 | 2012 |
| Glioma therapy and real‐time imaging of neural precursor cell migration and tumor regression K Shah, E Bureau, DE Kim, K Yang, Y Tang, R Weissleder, ... Annals of Neurology: Official Journal of the American Neurological …, 2005 | 231 | 2005 |
| Nanobodies: next generation of cancer diagnostics and therapeutics EY Yang, K Shah Frontiers in Oncology 10, 1182, 2020 | 220 | 2020 |
| In vivo imaging of β-galactosidase activity using far red fluorescent switch CH Tung, Q Zeng, K Shah, DE Kim, D Schellingerhout, R Weissleder Cancer research 64 (5), 1579-1583, 2004 | 212 | 2004 |
| Imaging of stem cell recruitment to ischemic infarcts in a murine model DE Kim, D Schellingerhout, K Ishii, K Shah, R Weissleder Stroke 35 (4), 952-957, 2004 | 196 | 2004 |
| Identification of genes conferring resistance to 5-fluorouracil BK Yoo, R Gredler, N Vozhilla, Z Su, D Chen, T Forcier, K Shah, ... Proceedings of the National Academy of Sciences 106 (31), 12938-12943, 2009 | 195 | 2009 |
| Therapeutic stem-cells for cancer treatment: hopes and hurdles in tactical warfare MF Corsten, K Shah The lancet oncology 9 (4), 376-384, 2008 | 194 | 2008 |
